Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 7703220)

1.
2.
3.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
4.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
5.
6.

Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder.

Chanen AM, Jovev M, Jackson HJ.

J Clin Psychiatry. 2007 Feb;68(2):297-306.

PMID:
17335330
7.

Quetiapine in patients with borderline personality disorder: an open-label trial.

Adityanjee, Romine A, Brown E, Thuras P, Lee S, Schulz SC.

Ann Clin Psychiatry. 2008 Oct-Dec;20(4):219-26. doi: 10.1080/10401230802467545.

PMID:
19034754
8.

[Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].

Chabrol H, Chouicha K, Montovany A, Callahan S.

Encephale. 2001 Mar-Apr;27(2):120-7. French.

PMID:
11407263
9.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
10.
11.

The psychopharmacology of borderline personality disorders.

Montgomery SA.

Acta Psychiatr Belg. 1987 May-Jun;87(3):260-6.

PMID:
3673629
12.

Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.

Mauri MC, Volonteri LS, Fiorentini A, Pirola R, Bareggi SR.

Expert Opin Pharmacother. 2007 Oct;8(14):2207-13.

PMID:
17927477
13.

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

Am J Psychiatry. 1993 Dec;150(12):1843-8.

PMID:
8238640
14.

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.

J Clin Psychiatry. 1999 Sep;60(9):598-603.

PMID:
10520978
15.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
16.

An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.

Simeon D, Baker B, Chaplin W, Braun A, Hollander E.

CNS Spectr. 2007 Jun;12(6):439-43.

PMID:
17545954
17.

Treatment of borderline personality disorder with risperidone.

Rocca P, Marchiaro L, Cocuzza E, Bogetto F.

J Clin Psychiatry. 2002 Mar;63(3):241-4.

PMID:
11926724
18.

Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.

Golubchik P, Sever J, Zalsman G, Weizman A.

Int Clin Psychopharmacol. 2008 Jul;23(4):228-31. doi: 10.1097/YIC.0b013e3282f94ae2.

PMID:
18446088
19.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151
20.

Diagnostic efficiency of borderline personality disorder criteria in hospitalized adolescents: comparison with hospitalized adults.

Becker DF, Grilo CM, Edell WS, McGlashan TH.

Am J Psychiatry. 2002 Dec;159(12):2042-7.

PMID:
12450954
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk